BEAM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Beam Therapeutics Inc

Watchlist Manager

Watchlist

Price: 28.29 USD -8.27%

Market Cap: $2.9B

	Beam Therapeutics Inc NASDAQ:BEAM	US
A	Aditya Infotech Ltd NSE:CPPLUS	IN
K	Kirin Holdings Co Ltd DUS:KIR	JP
	Paris Miki Holdings Inc TSE:7455	JP
S	Sovereign Metals Ltd OTC:SVMLF	AU
	Concurrent Technologies PLC F:FJV	UK
H	Hang Seng Bank Ltd XMUN:HSB	HK
A	Ascot Resources Ltd XMUN:BHQ	CA
	Terns Pharmaceuticals Inc F:430	US
	Windfall Geotek Inc XTSX:WIN	CA
G	Genfit SA OTC:GNFTF	FR
M	Manz AG XMUN:M5Z	DE
	Data I/O Corp NASDAQ:DAIO	US
	Gerresheimer AG OTC:GRRMF	DE
	Varia US Properties AG SIX:VARN	CH
	eHealth Inc NASDAQ:EHTH	US
S	Steel Connect Inc F:CGOB	US
N	NCC Group PLC F:NZB	UK
R	Resources Connection Inc F:RCO	US
P	Pharol SGPS SA XMUN:PTCA	PT

Profitability Summary

Beam Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-227%

Negative 3Y Average Operating Margin

-381%

Operating Margin is Increasing

-476% > -227%

Negative Net Margin

-40%

Negative 3Y Average Net Margin

-304%

Net Margin is Increasing

-408% > -40%

Negative Free Cash Flow Margin

-234%

Negative 3Y Average Free Cash Flow Margin

-332%

Free Cash Flow Margin is Increasing

-475% > -234%

Negative ROE

-6%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-134%

Declining ROIC

-147% > -150%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.